Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Michel

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
MMW Fortschritte Der Medizin|January 28, 2022
[Cardiovascular complications from cancer therapy]Lars Michel, Tienush Rassaf
Herz|January 30, 2024
[Heart and cancer: cardio-oncology]Lars Michel, Tienush Rassaf
European Journal of Medical Research|January 5, 2019
Cardio-oncology: need for novel structuresLars Michel, Tienush Rassaf
Herz|January 4, 2024
[Update cardio-oncology : Immune checkpoint inhibitor therapy]Lars Michel, Tienush Rassaf
Deutsche Medizinische Wochenschrift (1946)|November 17, 2022
[Drug-induced cardiomyopathies]Lars Michel, Tienush Rassaf
International Journal of Cardiology. Heart & Vasculature|September 14, 2019
Cardiotoxicity from immune checkpoint inhibitorsLars Michel, Tienush Rassaf, Matthias Totzeck
Current Heart Failure Reports|March 2, 2024
Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac DysfunctionLars Michel, Peter Ferdinandy, Tienush Rassaf
Basic Research in Cardiology|October 21, 2021
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicityLars Michel, Matthias Totzeck, Tienush Rassaf
Journal of Thoracic Disease|February 1, 2019
Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicityLars Michel, Tienush Rassaf, Matthias Totzeck
Herz|November 28, 2022
[2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy]Lars Michel, Matthias Totzeck, Tienush Rassaf
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
MMW Fortschritte Der Medizin|January 28, 2022
[Cardiovascular complications from cancer therapy]Lars Michel, Tienush Rassaf
Herz|January 30, 2024
[Heart and cancer: cardio-oncology]Lars Michel, Tienush Rassaf
European Journal of Medical Research|January 5, 2019
Cardio-oncology: need for novel structuresLars Michel, Tienush Rassaf
Herz|January 4, 2024
[Update cardio-oncology : Immune checkpoint inhibitor therapy]Lars Michel, Tienush Rassaf
Deutsche Medizinische Wochenschrift (1946)|November 17, 2022
[Drug-induced cardiomyopathies]Lars Michel, Tienush Rassaf
International Journal of Cardiology. Heart & Vasculature|September 14, 2019
Cardiotoxicity from immune checkpoint inhibitorsLars Michel, Tienush Rassaf, Matthias Totzeck
Current Heart Failure Reports|March 2, 2024
Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac DysfunctionLars Michel, Peter Ferdinandy, Tienush Rassaf
Basic Research in Cardiology|October 21, 2021
Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicityLars Michel, Matthias Totzeck, Tienush Rassaf
Journal of Thoracic Disease|February 1, 2019
Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicityLars Michel, Tienush Rassaf, Matthias Totzeck
Herz|November 28, 2022
[2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy]Lars Michel, Matthias Totzeck, Tienush Rassaf
Pageof 7